These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 12134250)
1. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway. Kato J; Kato N; Moriyama M; Goto T; Taniguchi H; Shiratori Y; Omata M J Infect Dis; 2002 Jul; 186(2):155-63. PubMed ID: 12134250 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein. Shimazaki T; Honda M; Kaneko S; Kobayashi K Hepatology; 2002 Jan; 35(1):199-208. PubMed ID: 11786977 [TBL] [Abstract][Full Text] [Related]
3. Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation. Krüger M; Beger C; Welch PJ; Barber JR; Manns MP; Wong-Staal F Mol Cell Biol; 2001 Dec; 21(24):8357-64. PubMed ID: 11713272 [TBL] [Abstract][Full Text] [Related]
4. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation. Pudi R; Ramamurthy SS; Das S J Virol; 2005 Aug; 79(15):9842-53. PubMed ID: 16014945 [TBL] [Abstract][Full Text] [Related]
5. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation. Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496 [TBL] [Abstract][Full Text] [Related]
6. Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells. Kanda T; Yokosuka O; Imazeki F; Fujiwara K; Nagao K; Saisho H Biochem Biophys Res Commun; 2005 Jun; 331(2):621-9. PubMed ID: 15850805 [TBL] [Abstract][Full Text] [Related]
7. Targeting internal ribosome entry site (IRES)-mediated translation to block hepatitis C and other RNA viruses. Dasgupta A; Das S; Izumi R; Venkatesan A; Barat B FEMS Microbiol Lett; 2004 May; 234(2):189-99. PubMed ID: 15135522 [TBL] [Abstract][Full Text] [Related]
8. Correlation between translation efficiency and outcome of combination therapy in chronic hepatitis C genotype 3. Yasmeen A; Hamid S; Granath FN; Lindström H; Elliott RM; Siddiqui AA; Persson MA J Viral Hepat; 2006 Feb; 13(2):87-95. PubMed ID: 16436126 [TBL] [Abstract][Full Text] [Related]
9. Roles of the polypyrimidine tract and 3' noncoding region of hepatitis C virus RNA in the internal ribosome entry site-mediated translation. Wang H; Shen XT; Ye R; Lan SY; Xiang L; Yuan ZH Arch Virol; 2005 Jun; 150(6):1085-99. PubMed ID: 15747050 [TBL] [Abstract][Full Text] [Related]
10. Riboproteomic analysis of polypeptides interacting with the internal ribosome-entry site element of foot-and-mouth disease viral RNA. Pacheco A; Reigadas S; Martínez-Salas E Proteomics; 2008 Nov; 8(22):4782-90. PubMed ID: 18937254 [TBL] [Abstract][Full Text] [Related]
11. RNA-binding protein hnRNP D modulates internal ribosome entry site-dependent translation of hepatitis C virus RNA. Paek KY; Kim CS; Park SM; Kim JH; Jang SK J Virol; 2008 Dec; 82(24):12082-93. PubMed ID: 18842733 [TBL] [Abstract][Full Text] [Related]
12. Cap and polyA tail enhance translation initiation at the hepatitis C virus internal ribosome entry site by a discontinuous scanning, or shunting, mechanism. Wiklund L; Spångberg K; Goobar-Larsson L; Schwartz S J Hum Virol; 2001; 4(2):74-84. PubMed ID: 11437317 [TBL] [Abstract][Full Text] [Related]
13. Interferon and ribavirin combination treatment synergistically inhibit HCV internal ribosome entry site mediated translation at the level of polyribosome formation. Panigrahi R; Hazari S; Chandra S; Chandra PK; Datta S; Kurt R; Cameron CE; Huang Z; Zhang H; Garry RF; Balart LA; Dash S PLoS One; 2013; 8(8):e72791. PubMed ID: 24009705 [TBL] [Abstract][Full Text] [Related]
14. The hepatitis C virus internal ribosome-entry site: a new target for antiviral research. Gallego J; Varani G Biochem Soc Trans; 2002 Apr; 30(2):140-5. PubMed ID: 12023841 [TBL] [Abstract][Full Text] [Related]
15. A mutational shift from domain III to II in the internal ribosome entry site of hepatitis C virus after interferon-ribavirin therapy. Ogata K; Kashiwagi T; Iwahashi J; Hara K; Honda H; Ide T; Kumashiro R; Kohara M; Sata M; Watanabe H; Hamada N Arch Virol; 2008; 153(8):1575-9. PubMed ID: 18592133 [TBL] [Abstract][Full Text] [Related]
16. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro. Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270 [TBL] [Abstract][Full Text] [Related]
17. Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus-1b: no association with efficacy of interferon therapy or serum HCV-RNA levels. Yamamoto C; Enomoto N; Kurosaki M; Yu SH; Tazawa J; Izumi N; Marumo F; Sato C Hepatology; 1997 Dec; 26(6):1616-20. PubMed ID: 9398006 [TBL] [Abstract][Full Text] [Related]
18. hnRNP L is required for the translation mediated by HCV IRES. Hwang B; Lim JH; Hahm B; Jang SK; Lee SW Biochem Biophys Res Commun; 2009 Jan; 378(3):584-8. PubMed ID: 19061868 [TBL] [Abstract][Full Text] [Related]
19. Increased inhibitory ability of conjugated RNA aptamers against the HCV IRES. Kikuchi K; Umehara T; Nishikawa F; Fukuda K; Hasegawa T; Nishikawa S Biochem Biophys Res Commun; 2009 Aug; 386(1):118-23. PubMed ID: 19501043 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of the internal ribosome entry site (IRES)-mediated translation of the hepatitis C virus: critical role of binding of the stem-loop IIId domain of IRES and the viral core protein. Shimoike T; Koyama C; Murakami K; Suzuki R; Matsuura Y; Miyamura T; Suzuki T Virology; 2006 Feb; 345(2):434-45. PubMed ID: 16297950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]